Université Lumière Lyon 2
Pôle de Psychologie Sociale (PôPS)
Research on Healthcare Performance (RESHAPE), Inserm U1290, Université Claude Bernard Lyon 1
- Oncology
- Diabetes
- Quality of life for patients and healthcare professionals
- Coping mechanisms and emotional regulation
- Community-based approaches
Baillat Léa holds a Bachelor's degree in Psychology from the University of Montpellier (2016-2019) and a Master's degree in Health Promotion and Education (PES), validated in 2021. Since October 2021, she has held the position of Study Engineer (IGE) within the Social Psychology Pole (PôPS) of the Inserm Unit 1290 “Research on Healthcare Performance” (RESHAPE) at the Université Lumière Lyon 2.
Endowed with excellent writing skills, her expertise focuses on qualitative methodologies, including thematic analysis, the interpretative phenomenological approach and trajectory analysis, the latter particularly in the context of the dyadic approaches in which she is interested. She is also proficient in conducting systematic reviews using the PRISMA method. Finally, she has a solid background in community-based research, and plays an active role as a mediator in the community-based research groups of which she is a member. Through her research and projects, she strives to deepen our understanding of the issues surrounding quality of life for patients and healthcare professionals, and to help improve care paths that are better adapted to patients' needs.
She has been and continues to be involved in several research projects. Among those already finalized:
- QUALITOP (H2020): Multidimensional monitoring of quality of life after cancer immunotherapy via an innovative digital platform.
- PERCE-NEIGE: Project on caregivers' perceptions of cognitive disorders linked to cancer treatment, aimed at improving patient care.
- OUTREA-19: Burn-out of intensive care physicians during the COVID-19 pandemic.
She is currently involved in the following projects:
- GLUCOGEN: Study on the use of high-speed sequencing to improve diagnosis and management of atypical diabetes.